RxDoctor Payments Data

Jill Jensen

Family · Las Vegas, NVNPI 1407562887

Payments from drug & device makers

$2,708in general payments, 2019–2025

Across 144 payments — averaging $18.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$581
  • Novo Nordisk$359
  • AstraZeneca$212
  • Lilly USA, LLC$194
  • Urgo Medical North America, LLC$162
  • Pfizer$161
  • plus $1K from 21 others

What the payments were for

  • Food & beverage$2,708100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,708 in reported general payments places this provider in the 85th percentile of 1,501 family providers in Nevada.

See all family providers in Nevada

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban33$29,572
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$14,959
JanuviaSitagliptin Phosphate11$7,195
SymbicortBudesonide/Formoterol Fumarate19$4,168
Albuterol Sulfate HfaAlbuterol Sulfate43$1,096
Atorvastatin Calcium65$563
Losartan Potassium53$522
Levothyroxine Sodium74$498
Bupropion XlBupropion Hcl11$482
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine13$481
Pantoprazole Sodium32$384
Lisinopril50$360
Rosuvastatin Calcium40$295
Amlodipine Besylate58$292
Tizanidine Hcl24$284

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$161$29,57233 claims
GSKTrelegy Ellipta$25$14,95914 claims
AstraZenecaSymbicort$212$4,16819 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,501 family providers in Nevada.

Other family in Las Vegas

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →